MedTrace Logo

Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain

NCT04829799 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-06-13

No results posted yet for this study

Summary

To compare the effect of intraoperative intracameral Omidria (Phenylephrine and Ketorolac 1.0%/0.3%) verses 1% Lidocaine on pain reduction during and after cataract surgery.

Conditions

  • Pain Reduction

Interventions

DRUG

1% preservative-free lidocaine

Instillation of intracameral lidocaine after initial paracentesis incision.

DRUG

Phenylephrine 1.0%/ Ketorolac 0.3%

Instillation of Omidria irrigation solution after paracentesis incision and in irrigation solution.

Sponsors & Collaborators

  • Omeros Corporation

    collaborator INDUSTRY

  • University of Florida

    lead OTHER

Principal Investigators

  • Eric Grieser, MD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2023-08-31
Completion
2023-08-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04829799 on ClinicalTrials.gov